LABORATORIOS FARMACEUTICOS ROVI, S.A. «...1112131415...» Page 13 out of 18 22/11/2021 10:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 November 2021 and 19 November 2021. Register number: 12840 16/11/2021 15:16 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements The Company informs of the termination of the Liquidity Agreement Register number: 12785 16/11/2021 07:35 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the presentation related to its strategy update because of its 2021 Capital Markets Day Register number: 12774 15/11/2021 13:24 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 November 2021 and 12 November 2021. Register number: 12764 05/11/2021 12:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Register number: 12612 03/11/2021 07:40 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the first nine months 2021 financial results presentation Register number: 12525 03/11/2021 07:36 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Register number: 12524 21/10/2021 18:19 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements La Sociedad informa sobre la realización de una aportación a las cuentas de efectivo y valores del Contrato de Liquidez Register number: 12297 21/10/2021 07:42 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Register number: 12278 07/10/2021 13:04 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Operaciones sobre acciones propias efectuadas en el tercer trimestre de 2021 en el marco del contrato de liquidez Register number: 12107 Notification modified by communication number 12000 dated 04/10/2021 (16:21) Page 13 out of 18 «...1112131415...»